Cellestia Biotech AG Switzerland

Research

Date range: 1 March 2021 - 28 February 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Cellestia Biotech AG published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Cellestia Biotech AG
Count Share
1 0.11

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.11

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.10

Compare Cellestia Biotech AG with other institutions

Collaboration

Date range: 1 March 2021 - 28 February 2022

International vs. domestic collaboration by Share

  • 0.00% Domestic
  • 100.00% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Cellestia Biotech AG by Share (0 total)


Top 10 international collaborators with Cellestia Biotech AG by Share (6 total)

  1. Cellestia Biotech AG and University of Arkansas for Medical Sciences (UAMS) (0.40)
    Cellestia Biotech AG0.11
    University of Arkansas for Medical Sciences (UAMS)0.30
  2. Cellestia Biotech AG and Indiana University (IU) (0.39)
    Cellestia Biotech AG0.11
    Indiana University (IU)0.29
  3. Cellestia Biotech AG and University of Rochester (UR) (0.24)
    Cellestia Biotech AG0.11
    University of Rochester (UR)0.13
  4. Cellestia Biotech AG and Stanford University (0.21)
    Cellestia Biotech AG0.11
    Stanford University0.11
  5. Cellestia Biotech AG and U.S. Department of Veterans Affairs (0.15)
    Cellestia Biotech AG0.11
    U.S. Department of Veterans Affairs0.04
  6. Cellestia Biotech AG and BioVinc LLC (0.13)
    Cellestia Biotech AG0.11
    BioVinc LLC0.03